AG013, a mouth rinse formulation of Lactococcus lactis secreting human Trefoil Factor 1, provides a safe and efficacious therapeutic tool for treating oral mucositis

Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers

Ricardo Spielberger, Patrick J. Stiff, William Bensinger et al. · New England Journal of Medicine · 2004 · 901 citations

Dentistry, Oral Medicine, Chemotherapy +15

Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis

Edward Rubenstein, Douglas E. Peterson, Mark Schubert et al. · Cancer · 2004 · 827 citations · Full text

Pharmacy, Oncology, Chemotherapy +16

Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10

Lothar Steidler, Sabine Neirynck, Nathalie Huyghebaert et al. · Nature Biotechnology · 2003 · 539 citations

Life Sciences, Biotechnology, Immunology +11

Gastric Mucosa Abnormalities and Tumorigenesis in Mice Lacking the pS2 Trefoil Protein

Olivier Lefèbvre, Marie‐Pierre Chenard, Régis Masson et al. · Science · 1996 · 496 citations

Medicine, Genetics, Oncology +17

Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma

Montserrat Vera‐Llonch, Gerry Oster, May Hagiwara et al. · Cancer · 2005 · 389 citations · Full text

Medicine, Oncology, Radiation Oncology +16